[Immunosuppressive treatment of skin diseases. I. Action of immunosuppressive drugs].
D000477:Alkylating Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D005938:Glucocorticoids / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D010587:Phagocytosis / Q000187:drug effects; D012867:Skin / Q000276:immunology; D012871:Skin Diseases / Q000188:drug therapy* / Q000276:immunology
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000961:Antilymphocyte Serum; D000963:Antimetabolites; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D006918:Hydroxyurea
Leczenie immunosupresyjne chorób skóry. I. Mechanizm działania środków immunosupresyjnych